BIOY · NASDAQ · ETF
GraniteShares YieldBOOST Biotech ETF (BIOY) Price, Holdings & Fees
GraniteShares YieldBOOST Biotech ETF (BIOY) closed at $841.73 on Oct 9, 2026, down 0.66% from the previous close of $847.30.
Share price, past year
1Y +20.57%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $841.73 |
| Sep 30, 2026 | $838.31 |
| Aug 31, 2026 | $814.22 |
| Jul 31, 2026 | $813.97 |
| Jun 30, 2026 | $766.94 |
| May 29, 2026 | $760.96 |
| Apr 30, 2026 | $735.67 |
| Mar 31, 2026 | $711.15 |
| Feb 27, 2026 | $716.56 |
| Jan 30, 2026 | $698.69 |
| Dec 31, 2025 | $696.28 |
| Nov 28, 2025 | $684.60 |
| Oct 31, 2025 | $683.93 |
Key statistics
- Expense ratio
- 1.07%
- as of Oct 31, 2025
- Net assets
- $693.2K
- as of Jun 30, 2026
- Holdings
- 3
- as of Jun 30, 2026
- 52-week range
- $667.27 – $850.28
GraniteShares YieldBOOST Biotech ETF's expense ratio is 1.07%: $107.00 a year on $10,000 invested.
Holdings
GraniteShares YieldBOOST Biotech ETF held 3 investments worth $693.21K as of Jun 30, 2026. Its largest holding was Treasury Bill, at 57.03% of the fund.
| # | Holding | % of fund | Value |
|---|---|---|---|
| 1 | Treasury Bill | 57.03% | $395.30K |
| 2 | The Options Clearing Corporation | 1.56% | $10.79K |
| 3 | The Options Clearing Corporation | −3.20% | −$22.17K |
Top 3 of 3 holdings, as of Jun 30, 2026. Percentages are of the fund's net assets.
What the fund owns
| Asset type | % of fund |
|---|---|
| Bonds and other debt | 57.03% |
| Derivatives | −1.64% |
| Country | % of fund |
|---|---|
| United States | 55.38% |
Shares of net assets from the fund's N-PORT report. Funds that borrow can add up to more than 100%, with borrowing (such as repurchase agreements) shown as a negative share.
Monthly total returns
Over the month to Jun 30, 2026, GraniteShares YieldBOOST Biotech ETF's total return was +0.96%, as reported to the SEC.
| Month | Total return |
|---|---|
| Jun 30, 2026 | +0.96% |
The fund's own total returns as reported to the SEC (N-PORT), including reinvested distributions. Not the sample prices above.
Fund profile
- Name
- GraniteShares YieldBOOST Biotech ETF
- Ticker
- BIOY
- Exchange
- NASDAQ
- Fund type
- ETF
- Trust
- GraniteShares ETF Trust
- SEC series ID
- S000086455
- SEC CIK
- 0001689873
- Fractional shares
- No
Recent SEC filings
- Aug 31, 2026
- Sep 4, 2026
- 485BPOSProspectus updateSep 2, 2026
- 485BPOSProspectus updateSep 2, 2026
- 485BPOSProspectus updateAug 21, 2026
- 485BPOSProspectus updateAug 21, 2026
- 485BPOSProspectus updateAug 21, 2026
- 485BPOSProspectus updateAug 21, 2026
Shareholder reports and prospectuses are filed by GraniteShares ETF Trust, the trust behind GraniteShares YieldBOOST Biotech ETF, and cover all of its funds.
Frequently asked questions
What is BIOY's price?
GraniteShares YieldBOOST Biotech ETF (BIOY) closed at $841.73 on Oct 9, 2026, down 0.66% from the previous close of $847.30.
What is BIOY's expense ratio?
GraniteShares YieldBOOST Biotech ETF's expense ratio is 1.07%: $107.00 a year on $10,000 invested.
What does BIOY hold?
GraniteShares YieldBOOST Biotech ETF held 3 investments worth $693.21K as of Jun 30, 2026. Its largest holding was Treasury Bill, at 57.03% of the fund. Its five largest holdings were Treasury Bill, The Options Clearing Corporation, The Options Clearing Corporation.
How has BIOY performed?
Over the month to Jun 30, 2026, GraniteShares YieldBOOST Biotech ETF's total return was +0.96%, as reported to the SEC.
Sources and methodology
Holdings, net assets and monthly returns come from the fund's N-PORT filing with the SEC, as of Jun 30, 2026 (filed Aug 31, 2026). The expense ratio is from the fund's prospectus or shareholder report, as of Oct 31, 2025. Prices are generated sample data for development. Data sources and disclosures